Related references
Note: Only part of the references are listed.Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis
D. A. Rodriguez et al.
CELL DEATH AND DIFFERENTIATION (2016)
Protein Inhibitor of Activated STAT3 Regulates Migration, Invasion, and Activation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis
Minxi Lao et al.
JOURNAL OF IMMUNOLOGY (2016)
Cytokines in rheumatoid arthritis - shaping the immunological landscape
Iain B. McInnes et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?
R. Mahony et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis
Somaiya Mateen et al.
CLINICA CHIMICA ACTA (2016)
Janus kinase inhibitors for rheumatoid arthritis
Kunihiro Yamaoka
CURRENT OPINION IN CHEMICAL BIOLOGY (2016)
Anti cytokine therapy in chronic inflammatory arthritis
Charlotte Thompson et al.
CYTOKINE (2016)
STAT5 in Cancer and Immunity
Aradhana Rani et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2016)
The Activity of JAK/STAT and NF-κB in Patients with Rheumatoid Arthritis
Jerzy Swierkot et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Biologic basis of osteoarthritis: state of the evidence
Charles J. Malemud
CURRENT OPINION IN RHEUMATOLOGY (2015)
SOCS3 and its role in associated diseases
Yanlin Yin et al.
HUMAN IMMUNOLOGY (2015)
Linear ubiquitination signals in adaptive immune responses
Fumiyo Ikeda
IMMUNOLOGICAL REVIEWS (2015)
The X-Linked Inhibitor of Apoptosis Protein Inhibitor Embelin Suppresses Inflammation and Bone Erosion in Collagen Antibody Induced Arthritis Mice
Anak A. S. S. K. Dharmapatni et al.
MEDIATORS OF INFLAMMATION (2015)
The diverse role of RIP kinases in necroptosis and inflammation
John Silke et al.
NATURE IMMUNOLOGY (2015)
RIPK1 and RIPK3: critical regulators of inflammation and cell death
Kim Newton
TRENDS IN CELL BIOLOGY (2015)
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL
Kate E. Lawlor et al.
NATURE COMMUNICATIONS (2015)
Programmed necrosis and necroptosis signalling
Maria Feoktistova et al.
FEBS JOURNAL (2015)
mTOR Signaling in T Cell Immunity and Autoimmunity
Yu Liu et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2015)
Therapeutic Targeting of the JAK/STAT Pathway
Saara Aittomaki et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Kinase inhibitors: The next generation of therapies in the treatment of rheumatoid arthritis
Lindsey A. Macfarlane et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2014)
XIAP Restricts TNF- and RIP3-Dependent Cell Death and Inflammasome Activation
Monica Yabal et al.
CELL REPORTS (2014)
Protein kinase small molecule inhibitors for rheumatoid arthritis: Medicinal chemistry/clinical perspectives
Charles J. Malemud et al.
WORLD JOURNAL OF ORTHOPEDICS (2014)
Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib
Enrico Derenzini et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Investigational Janus kinase inhibitors
Constantine S. Tam et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
STAT inhibitors for cancer therapy
Muhammad Furqan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition
Nadia J. Kershaw et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes
Jung-Yoon Choe et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Targeted drug development for arthritis
Charles J. Malemud
FUTURE MEDICINAL CHEMISTRY (2012)
NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death
Marie Anne O'Donnell et al.
IMMUNOLOGIC RESEARCH (2012)
Puma, a critical mediator of cell death - one decade on from its discovery
Pawe Hikisz et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2012)
Matrix Metalloproteinase-13 Expression in IL-1 beta-treated Chondrocytes by Activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT Pathways
Hyun Lim et al.
ARCHIVES OF PHARMACAL RESEARCH (2011)
Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis
Maria C. de Andres et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
A Cytokine-Centric View of the Pathogenesis and Treatment of Autoimmune Arthritis
Brian Astry et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Treating inflammation with the Janus Kinase inhibitor CP-690,550
Lalitha Vijayakrishnan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Emerging From the Shadows: Follicular Helper T Cells in Autoimmunity
Leah D. DiPlacido et al.
ARTHRITIS AND RHEUMATISM (2010)
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
Ana Luisa G. Calich et al.
CLINICAL RHEUMATOLOGY (2010)
Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Charles Jay Malemud et al.
CURRENT SIGNAL TRANSDUCTION THERAPY (2009)
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium
Anak A. S. S. K. Dharmapatni et al.
ARTHRITIS RESEARCH & THERAPY (2009)
XIAP regulates bi-phasic NF-κB induction involving physical interaction and ubiquitination of MEKK2
Gabriele Winsauer et al.
CELLULAR SIGNALLING (2008)
A mechanistic insight into SMAC peptide interference with XIAP-Bir2 inhibition of executioner caspases
Behnaz Ahangarian Abhari et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways
Charles J. Malemud
CURRENT OPINION IN PHARMACOLOGY (2007)
Emerging cytokine targets in rheumatoid arthritis
Darren L. Asquith et al.
CURRENT OPINION IN RHEUMATOLOGY (2007)
General nature of the STAT3-activated anti-inflammatory response
Karim C. El Kasmi et al.
JOURNAL OF IMMUNOLOGY (2006)
Regulation of cytokine signaling pathways by PIAS proteins
K Shuai
CELL RESEARCH (2006)
Fas (CD95)-related apoptosis and rheumatoid arthritis
SL Peng
RHEUMATOLOGY (2006)
Immunologic mechanisms in the pathogenesis of rheumatoid arthritis
GS Firestein
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2005)
STAT4 - A critical regulator of inflammation in vivo
MH Kaplan
IMMUNOLOGIC RESEARCH (2005)
Negative regulation of cytokine signaling and immune responses by SOCS proteins
A Yoshimura et al.
ARTHRITIS RESEARCH & THERAPY (2005)
An update on the cytokine network in rheumatoid arthritis
P Miossec
CURRENT OPINION IN RHEUMATOLOGY (2004)
A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1)
F Giordanetto et al.
PROTEIN ENGINEERING (2003)
Pathophysiological mechanisms in Osteoarthritis lead to novel therapeutic strategies
CJ Malemud et al.
CELLS TISSUES ORGANS (2003)
SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities
D De Souza et al.
BIOCHEMISTRY (2002)
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis
T Shouda et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Expression profile of protein tyrosine kinase genes in human osteoarthritis chondrocytes
S Islam et al.
OSTEOARTHRITIS AND CARTILAGE (2001)
STAT proteins: novel molecular targets for cancer drug discovery
J Turkson et al.
ONCOGENE (2000)
Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
AM Verhagen et al.
CELL (2000)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)